Research groups
Dominic Kelly
BRC Consultant in Paediatrics and Vaccinology.
- Honorary Senior Clinical Lecturer
Vaccines and vaccine preventable disease in childhood
I am a BRC funded consultant in paediatrics and vaccinology. I undertook clinical training in paediatrics in Oxford, Reading, Melbourne, Vancouver and Yorkshire. I completed a PhD in 2008 within the Oxford Vaccine Group and began my current post in 2009. I divide my time between working in general paediatrics and paediatric infectious disease/immunology at the Children’s Hospital in Oxford and vaccine related research within the Oxford Vaccine Group.
Recent publications
-
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), J Immunol Methods, 534
-
Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
Peters NE. et al, (2024), N Engl J Med, 391, 56 - 59
-
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.
Kandasamy R. et al, (2024), Vaccine
-
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.
Gillard J. et al, (2024), Nat Commun, 15
-
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health, 8, 190 - 200